ALPA vs LYKALABS: Stock Comparison

ALPA LABORATORIES vs LYKALABSUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

LYKALABS is the larger company by market capitalisation. ALPA LABORATORIES shows a higher ROE, lower leverage and a higher ROCE, while LYKALABS shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALPA leads 6; LYKALABS leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALPALYKALABS

Valuation lens

What price are you paying?

Market CapContext only
₹133 Cr
₹285 Cr
P/E RatioLYKALABS has the lower reading
12.09x
0x
P/B RatioALPA has the lower reading
0.77x
2.67x
EPSLYKALABS has the higher reading
₹0.47
₹0.57
Book ValueContext only
₹88.53
₹25.12
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
LYKALABS is the larger company
₹285 Cr vs ₹133 Cr
P/E Ratio
LYKALABS has a lower P/E
0x vs 12.09x
P/B Ratio
ALPA has a lower P/B
0.77x vs 2.67x
EPS
LYKALABS has higher earnings per share
₹0.57 vs ₹0.47
Revenue Growth (TTM YoY)
LYKALABS has faster revenue growth
0% vs -21.4%
Qtr Profit Growth
LYKALABS has stronger quarterly profit growth
-2.56% vs -5.6%
ROE
ALPA has a higher ROE
7.58% vs -37.11%
ROCE
ALPA has a higher ROCE
7.63% vs -22.29%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALPALYKALABS
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALPALYKALABS
Live Price₹62.71₹74.83
Day Change-0.93%1.19%
Volume9,19488,556
52-Week High₹99₹101.99
52-Week Low₹46.1₹44.1
Distance from 52W High-36.66%-26.63%

Valuation

MetricALPALYKALABS
Market Cap₹133 Cr₹285 Cr
P/E Ratio12.09x0x
P/B Ratio0.77x2.67x
EPS₹0.47₹0.57
Book Value₹88.53₹25.12
Dividend Yield0%0%

Growth

MetricALPALYKALABS
Revenue Growth (TTM YoY)-21.4%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth-5.6%-2.56%

Profitability & Leverage

MetricALPALYKALABS
ROE7.58%-37.11%
ROCE7.63%-22.29%
Net Margin14.33%-7.81%
Operating Margin15.19%-24.74%
Debt to Equity0.01x0.56x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALPALYKALABS
Promoter Holding57.19%58.45% 0.29 pp
FII Holding0.35% 0.03 pp0.17% 0.12 pp
DII Holding0.07% 0.07 pp0.66% 0.01 pp
Public Holding42.39% 0.04 pp40.72% 0.16 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALPA LABORATORIES and LYKALABS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.